BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 8504975)

  • 1. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K; Chijiiwa K
    Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
    Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
    Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
    Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM
    Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gall bladder bile and endoscopically obtained duodenal bile.
    Janowitz P; Swobodnik W; Wechsler JG; Zöller A; Kuhn K; Ditschuneit H
    Gut; 1990 Dec; 31(12):1407-10. PubMed ID: 2265783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile.
    Hussaini SH; Pereira SP; Murphy GM; Dowling RH
    Hepatology; 1995 Dec; 22(6):1735-44. PubMed ID: 7489982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endoscopic sphincterotomy on gall bladder bile lithogenicity and motility.
    Sharma BC; Agarwal DK; Baijal SS; Negi TS; Choudhuri G; Saraswat VA
    Gut; 1998 Feb; 42(2):288-92. PubMed ID: 9536957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.
    Makino I; Chijiiwa K; Higashijima H; Nakahara S; Kishinaka M; Kuroki S; Mibu R
    Gut; 1994 Dec; 35(12):1760-4. PubMed ID: 7829016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.
    Harvey PR; Rupar CA; Gallinger S; Petrunka CN; Strasberg SM
    Gut; 1986 Apr; 27(4):374-81. PubMed ID: 3957108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis.
    Núñez L; Amigo L; Mingrone G; Rigotti A; Puglielli L; Raddatz A; Pimentel F; Greco AV; González S; Garrido J
    Gut; 1995 Sep; 37(3):422-6. PubMed ID: 7590442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterol crystals, cholesterol saturation of bile and biliary lithiasis].
    Poupon R; Chrétien Y; Darnis F
    Gastroenterol Clin Biol; 1984 Mar; 8(3):260-3. PubMed ID: 6714561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of binding of ionised calcium on the in vitro nucleation of cholesterol and calcium bilirubinate in human gall bladder bile.
    Gallinger S; Harvey PR; Petrunka CN; Strasberg SM
    Gut; 1986 Nov; 27(11):1382-6. PubMed ID: 3098634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal bile examination in identifying potential non-responders to bile salt treatment and its comparison with gall bladder bile examination.
    Agarwal DK; Choudhuri G; Saraswat VA; Negi TS; Kapoor VK; Saxena R
    Gut; 1994 Jan; 35(1):112-6. PubMed ID: 8307430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.
    Rhodes M; Allen A; Dowling RH; Murphy G; Lennard TW
    Gut; 1992 Aug; 33(8):1113-7. PubMed ID: 1398238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary proteins and their redox status changes in gallstone patients.
    Grattagliano I; Wang DQ; Di Ciaula A; Diogo CV; Palasciano G; Portincasa P
    Eur J Clin Invest; 2009 Nov; 39(11):986-92. PubMed ID: 19656169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of efferent biliary ducts on the composition of bile acids. Studies on subjects with cholesterol gall stones and a stone-free control group].
    Brühl W
    Z Gastroenterol; 1975 Dec; 13(8):690-4. PubMed ID: 1224757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.